BT

Brain Tumor Pathology

Brain Tumor Pathology is the official journal of the Japan Society of Brain Tumor Pathology. It publishes international clinical and experimental research relating to brain tumors, especially brain tumor pathology, and has been published since 1983. The journal accepts submissions from any country and publishes original articles, case reports, rapid short communications, instructional lectures, review articles, letters to the editor, and topics.

Looking to publish in Brain Tumor Pathology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Clinical Neurology, Oncology, Pathology
Impact Factor 3
Quartile Q2
Open Access Type Hybrid
ISSN 1433-7398
eISSN 1861-387X
Invitation Only No
Cost Range Open access APC: £2990.00 GBP / $4490.00 USD / €3490.00 EUR; subscription publishing: no APC charges apply.

Submission Instructions

Brain Tumor Pathology accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter A cover letter must be provided with the manuscript. The cover letter must confirm approval for publication by all co-authors and responsible institutional authorities.
Abstract An abstract is required. Abstract must not exceed 200 words. The abstract structure type is not specified. No mandatory abstract headings are specified.
Manuscript Manuscript must be limited to 6,400 words including title page, abstract, text, illustrations, tables, and references. Original Articles must be divided into title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgements, conflict of interest, references, tables, and figure legends. Manuscripts must include 3 to 5 keywords and the number of words on the title page.
References Citations must be numbered in square brackets, and references must be alphabetized by first-author surname and numbered consecutively with the first three authors plus et al used for works with more than four authors.
Figures & Tables Original Articles may include no more than six figures or tables. Figure captions must be included in the manuscript text file, and figures must be supplied electronically. Tables and figures must be numbered in Arabic numerals and cited in the text in consecutive numerical order.
Reformat to Brain Tumor Pathology using Livewrite Premium

Review Articles

Cover Letter A cover letter is required. The cover letter must include approval of publication by all co-authors and the responsible authorities at the institute where the work was carried out.
Abstract An abstract may be included. Abstract must not exceed 200 words.
Manuscript Manuscript is limited to 6,400 words in total. Manuscript must include 3 to 5 keywords and a statement identifying who had the idea for the article, who performed the literature search and data analysis, and who drafted or critically revised the work.
References Citations must be numbered in square brackets, and the reference list must be alphabetized by the first author's last name and numbered consecutively, using the first three authors plus et al for works with more than four authors.
Figures & Tables Figure captions must be included in the manuscript text file rather than in the figure file, and all figures must be supplied electronically. Tables and figures must be numbered with Arabic numerals and cited in the text in consecutive numerical order, and each must have a caption.
Reformat to Brain Tumor Pathology using Livewrite Premium

Case Reports

Cover Letter A cover letter must be provided with the manuscript. The cover letter must confirm approval for publication by all co-authors and the responsible authorities at the institute where the work was carried out.
Abstract An abstract is required. Abstract must not exceed 200 words. Abstract structure is not explicitly specified. No mandatory abstract headings are explicitly specified.
Manuscript Case Reports must be limited to 4,000 words including title page, abstract, text, illustrations, tables and references. Case Reports must be divided into title page, abstract, keywords, introduction, clinical summary, pathological findings, discussion, acknowledgements, conflict of interest, references, tables and figure legends. Manuscripts must include 3 to 5 keywords.
References References must be cited in the text by numbers in square brackets, with the reference list alphabetized by first-author surname and numbered consecutively, and references with more than four authors listing the first three authors followed by et al.
Figures & Tables Case Reports may include no more than four figures or tables. Figure captions must be included in the manuscript text file rather than in the figure files. Tables and figures must be numbered in Arabic numerals and cited in the text in consecutive numerical order.
Reformat to Brain Tumor Pathology using Livewrite Premium

Rapid Short Communications

Cover Letter A cover letter is required. Cover letter must include approval of publication by all co-authors and the responsible authorities at the institute where the work was carried out.
Abstract Abstract must not exceed 200 words.
Manuscript Manuscript must not exceed 3,200 words. Rapid Short Communications may combine the Results and Discussion sections. Manuscript must include 3 to 5 keywords.
References References must be cited in the text with numbers in square brackets and listed alphabetically by first-author surname, numbered consecutively, using the first three authors plus et al for works with more than four authors.
Figures & Tables Rapid Short Communications may include no more than three figures or tables. Figures must be supplied electronically, and figure captions must be included in the manuscript text file rather than in the figure file. Figures and tables must be numbered with Arabic numerals and cited in the text in consecutive numerical order.
Reformat to Brain Tumor Pathology using Livewrite Premium

Letters To The Editor

Cover Letter A cover letter must be provided with the manuscript. The cover letter must confirm approval for publication by all co-authors and the responsible authorities at the institute where the work was carried out.
Abstract Letters To The Editor must not include an abstract.
Manuscript Letters To The Editor must not exceed 1,600 words in total. Letters To The Editor must not use sections such as Introduction, Materials and Methods, Results, and Discussion. The manuscript must include 3 to 5 keywords.
References Letters To The Editor may include no more than 10 references. Citations must be numbered in square brackets, and references must be alphabetized by the first author's last name and numbered consecutively with the first three authors listed followed by et al. for works with more than four authors.
Figures & Tables Letters To The Editor may include no more than two figures or tables. Figure captions must be included in the manuscript text file rather than in the figure files. Tables and figures must be numbered with Arabic numerals and cited in the text in consecutive numerical order.
Reformat to Brain Tumor Pathology using Livewrite Premium

Recent Publications

Rapid immunohistochemistry for intraoperative differentiation between high-grade gliomas and primary central nervous system lymphomas: a multicenter prospective study

Takahiro Ono, Hiroaki Shimizu, Yuko Hiroshima, Hiroshi Nanjo, Kazutoshi Hida, Kazuhiro Tanaka, Shunsuke Terasaka, Hirokazu Sugino, Zenichi Tanei, Yoshinori Kodama, Tomoo Itoh, Takashi Sasayama, Kyoko Nomura, Shinya Tanaka, Kazuhiro Imai, Yoshihiro Minamiya, Akiteru Goto, Yasufumi Omori, Mishie Tanino, Ryuta Nakamura, Yoichi Akagami

10.1007/s10014-026-00544-4
View Publication

Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype, of the adult cerebellum: a report of 2 cases

Kaishi Satomi, Yukino Nikai, Kuniaki Saito, Miho Gomyo, Kazuhiro Tsuchiya, Kiyotaka Nagahama, Nobuyoshi Sasaki, Keiichi Kobayashi, Yoji Tanaka, Motoo Nagane, Junji Shibahara

10.1007/s10014-026-00545-3
View Publication

Spinal EWSR1::CREM fused mesenchymal tumor: an extracranial CNS counterpart of intracranial mesenchymal tumor, FET::CREB‑fusion positive

Seung-Ho Seo, Ki-Jeong Kim, Jae-Koo Lee, Kwang Ui Hong, Seung-Jae Hyun, Gheeyoung Choe, Kyu Sang Lee

10.1007/s10014-026-00542-6
View Publication

Gliosarcoma of the craniovertebral junction with loss of H3K27me3: a case report with molecular profiling

Tomoko Ikemoto, Hirotaka Hasegawa, Taijun Hana, Mayu Kanbe, Chiaki Murakami, Hiroki Imada, Morihiro Higashi, Shunya Hanakita

10.1007/s10014-026-00543-5
View Publication

Dual TERT promoter mutations in glioblastoma, IDH-wildtype: a case report with preclinical investigations

Yohei Miyake, Kensuke Tateishi, Hinako Okagawa, Akihide Koyama, Emi Hirata, Kanoko Sasaoka, Shuna Saito, Shuto Fushimi, Manabu Natsumeda, Erika Muraoka, Shoji Yamanaka, Satoshi Fujii, Tetsuya Yamamoto

10.1007/s10014-026-00540-8
View Publication

Frequently asked questions

How long does it take to publish?

Authors will in principle be advised within 4 weeks of acceptance, rejection, or required revision of the manuscript. Electronic submission reduces editorial processing and reviewing times and shortens overall publication times.

Reformat to Brain Tumor Pathology using Livewrite Premium

Is a cover letter required?

A cover letter is required with the manuscript submission.

Reformat to Brain Tumor Pathology using Livewrite Premium

What are the publication costs?

Open access APC: £2990.00 GBP / $4490.00 USD / €3490.00 EUR. Subscription publishing has no APC charges.

Reformat to Brain Tumor Pathology using Livewrite Premium

Research Topics

Glioma Diagnosis and Treatment Meningioma and schwannoma management Neurofibromatosis and Schwannoma Cases Neuroblastoma Research and Treatments Brain Metastases and Treatment Sarcoma Diagnosis and Treatment Chromatin Remodeling and Cancer Vascular Malformations Diagnosis and Treatment Pituitary Gland Disorders and Treatments CNS Lymphoma Diagnosis and Treatment Cancer, Hypoxia, and Metabolism MicroRNA in disease regulation Radiomics and Machine Learning in Medical Imaging Hedgehog Signaling Pathway Studies Bone Tumor Diagnosis and Treatments Head and Neck Surgical Oncology Lymphoma Diagnosis and Treatment Cancer Genomics and Diagnostics Epigenetics and DNA Methylation Cancer-related molecular mechanisms research Ocular Oncology and Treatments Cancer-related Molecular Pathways Cerebrospinal fluid and hydrocephalus Soft tissue tumor case studies Adrenal and Paraganglionic Tumors

Related Journals

CC
Cancer Cytopathology WILEY
NS
Naunyn-Schmiedeberg s Archives of Pharmacology Springer Science+Business Media
Mi
Mindfulness Springer Science+Business Media
TA
Therapeutic Advances in Neurological Disorders SAGE Publishing
AO
Archives of Toxicology Springer Science+Business Media
JO
Journal of Pathology and Translational Medicine Korean Society of Pathologists & the Korean Society for Cytopathology